Sarantis Worldwide

SARANTIS S.A., in its practice of providing accurate and timely information to investors and in accordance with the articles 4.1.2 και 4.1.3.15.1 of the Athens Stock Exchange Regulation, announces the amendment of its Financial Calendar for the year 2024 in relation to H1 2024 Financial Results announcement as follows:

Monday 2 September 2024: H1 2024 Financial Results release
Tuesday 3 September 2024: H1 2024 Analysts’ and Investors’ conference call

The company would like to clarify that the financial results will be released at the website of Athens Exchange www.helex.gr and at the Company's website www.sarantisgroup.com.

2024 Financial Calendar Update (189.1KB)

Sarantis Group to Become Exclusive Distributor of Jordan in Greek Pharmacies

Sarantis Group announces that, following an agreement with Orkla Health AS, it will assume the exclusive distribution of Jordan products in Greek pharmacies as of February 1, 2026. The addition of Jordan to the Group’s portfolio represents a collaboration of strategic importance, further strengthening the Group’s presence in the Greek pharmacy channel and significantly expanding its footprint in the oral hygiene category.

Contact

SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com

Connect with us

We're always looking to connect with those who share an interest.
Management of Sarantis Group encourages everyone to Speak Up and report any inappropriate behaviour or practice. SARANTIS Group Speak Up

Stay Tuned

Website Design & Development by

Change cookies consent Revoke cookies consent

Sarantis Worldwide

Visit our group site

Or choose a location

The Group

Our Brands

Sustainability

Investor Relations

News & Media

Careers in Sarantis

Who we are

What we do

Our People